[The copper chelating effect of D-penicillamine in the long-term therapy of progressive chronic polyarthritis].
D000328:Adult; D000886:Anthropometry; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001798:Blood Proteins / Q000032:analysis; D002908:Chronic Disease; D003300:Copper / Q000097:blood* / Q000652:urine; D004906:Erythrocyte Count; D005260:Female; D005385:Fingers; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007958:Leukocyte Count; D008134:Long-Term Care; D010396:Penicillamine / Q000627:therapeutic use*; D012709:Serum Albumin / Q000032:analysis; D012712:Serum Globulins / Q000032:analysis
D001798:Blood Proteins; D006454:Hemoglobins; D012709:Serum Albumin; D012712:Serum Globulins; D003300:Copper; D010396:Penicillamine
Die kupferchelierende Wirkung von D-Penicillamin in der Langzeittherapie der progredient chronischen Polyarthritis.